Qian-Zhong Song , Bing-Yao Liu , Si-Wei Wang , Hai-Yan Wang , Hui Cheng , Jun-Hua Chen , Qi-Feng Li , Sen Li , Xiu-Min Lu , Yong-Tang Wang
{"title":"The role of short-chain fatty acids and neuroinflammation in PTSD pathogenesis: A gut microbial perspective","authors":"Qian-Zhong Song , Bing-Yao Liu , Si-Wei Wang , Hai-Yan Wang , Hui Cheng , Jun-Hua Chen , Qi-Feng Li , Sen Li , Xiu-Min Lu , Yong-Tang Wang","doi":"10.1016/j.pbb.2026.174157","DOIUrl":null,"url":null,"abstract":"<div><div>Exposure to severe psychological trauma is a recognized etiological precursor to post-traumatic stress disorder (PTSD), a potentially debilitating psychiatric condition. Increasing evidence indicates a strong connection between mental disorders and the metabolic system, in which the gut microbiota, as a key component, exerts significant influence on psychiatric health. The gut is often referred to as the “second brain”, the gut engages in bidirectional communication with the central nervous system to maintain physiological homeostasis. Trauma affecting the nervous system and cognitive functions such as learning and memory can disrupt the gut microbial community and even trigger inflammatory responses. Conversely, changes in the gut microbiota can adversely affect neurocognitive function. This review systematically summarizes the bidirectional relationship between PTSD and gut microbiota, the pathways through which microbial dysbiosis influences PTSD symptoms, and the underlying mechanisms involving immune regulation, microbial metabolites, and vagus nerve signaling. It also discusses microbiota-based intervention strategies for PTSD, aiming to provide a theoretical foundation for microbial-targeted therapeutic approaches.</div></div>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":"260 ","pages":"Article 174157"},"PeriodicalIF":2.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Biochemistry and Behavior","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091305726000122","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Exposure to severe psychological trauma is a recognized etiological precursor to post-traumatic stress disorder (PTSD), a potentially debilitating psychiatric condition. Increasing evidence indicates a strong connection between mental disorders and the metabolic system, in which the gut microbiota, as a key component, exerts significant influence on psychiatric health. The gut is often referred to as the “second brain”, the gut engages in bidirectional communication with the central nervous system to maintain physiological homeostasis. Trauma affecting the nervous system and cognitive functions such as learning and memory can disrupt the gut microbial community and even trigger inflammatory responses. Conversely, changes in the gut microbiota can adversely affect neurocognitive function. This review systematically summarizes the bidirectional relationship between PTSD and gut microbiota, the pathways through which microbial dysbiosis influences PTSD symptoms, and the underlying mechanisms involving immune regulation, microbial metabolites, and vagus nerve signaling. It also discusses microbiota-based intervention strategies for PTSD, aiming to provide a theoretical foundation for microbial-targeted therapeutic approaches.
期刊介绍:
Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.